As of 2025-11-08, the Relative Valuation of Rapt Therapeutics Inc (RAPT) is (61.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 28.86 USD, the upside of Rapt Therapeutics Inc based on Relative Valuation is -313.6%.
The range of the Relative Valuation is (46.23) - (83.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.8x - 12.9x | 8.8x |
| Forward P/E multiples | 7.2x - 13.4x | 10.3x |
| Fair Price | (46.23) - (83.05) | (61.65) |
| Upside | -260.2% - -387.8% | -313.6% |
| Date | P/E |
| 2025-11-07 | -4.49 |
| 2025-11-06 | -4.51 |
| 2025-11-05 | -4.39 |
| 2025-11-04 | -4.43 |
| 2025-11-03 | -4.56 |
| 2025-10-31 | -4.69 |
| 2025-10-30 | -4.61 |
| 2025-10-29 | -4.63 |
| 2025-10-28 | -4.68 |
| 2025-10-27 | -4.68 |
| 2025-10-24 | -4.59 |
| 2025-10-23 | -4.66 |
| 2025-10-22 | -4.66 |
| 2025-10-21 | -5.21 |
| 2025-10-20 | -5.23 |
| 2025-10-17 | -4.56 |
| 2025-10-16 | -4.49 |
| 2025-10-15 | -4.20 |
| 2025-10-14 | -3.88 |
| 2025-10-13 | -4.09 |
| 2025-10-10 | -4.16 |
| 2025-10-09 | -4.66 |
| 2025-10-08 | -4.57 |
| 2025-10-07 | -4.51 |
| 2025-10-06 | -4.64 |
| 2025-10-03 | -4.68 |
| 2025-10-02 | -4.52 |
| 2025-10-01 | -4.23 |
| 2025-09-30 | -4.01 |
| 2025-09-29 | -4.13 |
| 2025-09-26 | -4.10 |
| 2025-09-25 | -3.80 |
| 2025-09-24 | -3.72 |
| 2025-09-23 | -3.26 |
| 2025-09-22 | -3.13 |
| 2025-09-19 | -3.08 |
| 2025-09-18 | -3.18 |
| 2025-09-17 | -2.80 |
| 2025-09-16 | -2.74 |
| 2025-09-15 | -2.70 |
| 2025-09-12 | -2.52 |
| 2025-09-11 | -2.44 |
| 2025-09-10 | -2.20 |
| 2025-09-09 | -2.11 |
| 2025-09-08 | -2.06 |
| 2025-09-05 | -2.01 |
| 2025-09-04 | -1.98 |
| 2025-09-03 | -1.76 |
| 2025-09-02 | -1.84 |
| 2025-08-29 | -1.77 |